Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Eur J Clin Microbiol Infect Dis ; 40(11): 2295-2303, 2021 Nov.
Article in English | MEDLINE | ID: covidwho-1479485

ABSTRACT

The aim of this study is to present the first nationwide microbiological and epidemiological study of invasive group A Streptococcus (iGAS) disease in Spain. One thousand eight hundred ninety-three iGAS isolates were analyzed over 2007-2019. emm typing was performed by sequencing the gene's variable 5' end, exotoxin genes were identified by PCR, and antimicrobial susceptibility explored via the E test and disk diffusion. Five hundred twenty-three isolates were associated with sepsis, 292 with cellulitis, 232 with scarlet fever, 153 with pneumonia, 141 with streptococcal toxic shock syndrome, and 94 with necrotizing fasciitis. The most prevalent emm types were emm1 (449/1893 isolates), emm89 (210/1893), emm3 (208/1893), emm4 (150/1893), emm12 (112/1893) emm6 (107/1893), emm87 (89/1893), emm28 (88/1893), emm75 (78/1893), emm77 (78/1893), emm11 (58/1893), and emm22 (35/1893). emm1, emm3, emm4, and emm6 were the predominant types affecting children (mostly respiratory infections), while emm11, emm77, and emm89 prevailed in the elderly (mostly skin infections). Each emm type was associated with one or more exotoxin gene (spe, sme, and ssa) profiles. speA was detected in 660 isolates, speB in 1829, speC in 1014, speF in 1826, speG in 1651, speJ in 716, speH in 331, smeZ in 720, and ssa in 512. Isolates with speA were associated with the most severe infections. Penicillin susceptibility was universal. Two hundred twenty-four isolates were resistant to tetracycline, 169 to erythromycin, and 81 to clindamycin. Tetracycline, erythromycin, and clindamycin resistance rates declined over the study period. The above information could serve as the basis for continued surveillance efforts designed to control disease cause by this bacterium.


Subject(s)
Streptococcal Infections/microbiology , Streptococcus pyogenes/isolation & purification , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Carrier Proteins/genetics , Carrier Proteins/metabolism , Child , Child, Preschool , Erythromycin/pharmacology , Exotoxins/genetics , Exotoxins/metabolism , Female , Humans , Infant , Male , Membrane Proteins/genetics , Membrane Proteins/metabolism , Microbial Sensitivity Tests , Middle Aged , Penicillins/pharmacology , Spain/epidemiology , Streptococcal Infections/epidemiology , Streptococcus pyogenes/classification , Streptococcus pyogenes/drug effects , Streptococcus pyogenes/genetics , Young Adult
2.
Pediatr Infect Dis J ; 40(8): e313-e316, 2021 08 01.
Article in English | MEDLINE | ID: covidwho-1305446

ABSTRACT

Masking and social distancing have been adopted to mitigate the severe acute respiratory syndrome coronavirus 2 pandemic. We evaluated the indirect impact of severe acute respiratory syndrome coronavirus 2 prevention strategies on invasive Staphylococcus aureus, Streptococcus pneumoniae (pneumococcus) and Group A Streptococcus in Houston area children. We observed a decline in invasive pneumococcal disease and invasive Group A Streptococcus temporally associated with social distancing/masking/school closures.


Subject(s)
COVID-19/epidemiology , Pneumococcal Infections/epidemiology , Staphylococcal Infections/epidemiology , Streptococcal Infections/epidemiology , COVID-19/microbiology , COVID-19/prevention & control , Child , Coinfection/epidemiology , Coinfection/microbiology , Coinfection/virology , Hospitalization , Humans , Pandemics , Pneumococcal Infections/prevention & control , Pneumococcal Infections/virology , Prospective Studies , SARS-CoV-2/isolation & purification , Staphylococcal Infections/prevention & control , Staphylococcal Infections/virology , Staphylococcus aureus/isolation & purification , Streptococcal Infections/prevention & control , Streptococcal Infections/virology , Streptococcus pneumoniae/isolation & purification , Streptococcus pyogenes/isolation & purification
3.
Am J Trop Med Hyg ; 102(6): 1208-1209, 2020 06.
Article in English | MEDLINE | ID: covidwho-107974

ABSTRACT

The early shortage of novel coronavirus disease (COVID-19) tests in the United States led many hospitals to first screen for common respiratory pathogens, and only if this screen was negative to proceed with COVID-19 testing. We report a case of a 56-year-old woman with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) coinfection with group A Streptococcus. The initial testing strategy resulted in delays in both diagnosis and implementation of appropriate precautions. Underlined is the importance of testing for both SARS-CoV-2 and other common respiratory pathogens during the current pandemic.


Subject(s)
Betacoronavirus/pathogenicity , Chronic Pain/diagnostic imaging , Coronavirus Infections/diagnostic imaging , Hypertension/diagnostic imaging , Lung/diagnostic imaging , Pneumonia, Viral/diagnostic imaging , Streptococcal Infections/diagnostic imaging , Antibodies, Monoclonal, Humanized/therapeutic use , Azithromycin/therapeutic use , Betacoronavirus/drug effects , Betacoronavirus/isolation & purification , COVID-19 , Ceftriaxone/therapeutic use , Chicago , Chronic Pain/immunology , Chronic Pain/pathology , Chronic Pain/therapy , Coinfection , Coronavirus Infections/immunology , Coronavirus Infections/pathology , Coronavirus Infections/therapy , Extracorporeal Membrane Oxygenation , Female , Humans , Hydroxychloroquine/therapeutic use , Hypertension/immunology , Hypertension/pathology , Hypertension/therapy , Lung/drug effects , Lung/pathology , Lung/virology , Middle Aged , Pandemics , Pneumonia, Viral/immunology , Pneumonia, Viral/pathology , Pneumonia, Viral/therapy , SARS-CoV-2 , Streptococcal Infections/immunology , Streptococcal Infections/pathology , Streptococcal Infections/therapy , Streptococcus pyogenes/drug effects , Streptococcus pyogenes/isolation & purification , Streptococcus pyogenes/pathogenicity , Tomography, X-Ray Computed , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL